GlassScriptPhysician profile
Omer L Burnett
NPI 1891905840
$2,050.17
in general payments reported to CMS, 2019-2025
18 companies · $637 in 2025
The $637 reported for 2025 was more than what 79% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.18 · 2020: $33.22 · 2021: $413 · 2022: $438 · 2023: $88.69 · 2024: $350 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $758 · Travel and Lodging: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $758.49 |
| Travel and Lodging | $317.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioprotect Medical, INC. | $543.74 | 2025 | Bioprotect Balloon Implant System |
| Boston Scientific Corporation | $374.38 | 2021-2025 | Spaceoar Vue System - 10ml |
| Astellas Pharma US INC | $315.66 | 2021-2023 | Xtandi |
| Janssen Biotech, INC. | $205.43 | 2021-2022 | |
| Varian Medical Systems, INC. | $136.76 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $74.11 | 2020-2022 | |
| Myriad Genetic Laboratories, INC. | $70.81 | 2021-2022 | |
| Novocure INC. | $56.69 | 2023-2024 | Optune |
| Regeneron Healthcare Solutions, INC. | $49.24 | 2024 | Libtayo |
| Blue Earth Diagnostics | $44.80 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $39.67 | 2022 | |
| Progenics Pharmaceuticals, INC. | $35.66 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $28.98 | 2023 | |
| Medtronic, INC. | $17.48 | 2021 | |
| Seagen INC. | $15.52 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.05 | 2021 | |
| Eisai INC. | $13.17 | 2021 | |
| Myovant Sciences INC. | $13.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omer Burnett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.